"Tossing a coin:" defining the excessive use of short-acting beta2 -agonists in asthma-the views of general practitioners and asthma experts in primary and secondary care

NPJ Primary Care Respiratory Medicine
Shauna McKibbenChris Griffiths

Abstract

The National Review of Asthma Deaths (NRAD) identified high prescribing of short-acting beta2-agonists (SABAs) as a key factor in over 40% of deaths. We interviewed asthma experts from both a hospital background (n = 5) and a primary care background (n = 8), and general practitioners delivering asthma care (n = 8), to identify how SABA use is defined and perceived. We identified disparity in how acceptable SABA use is defined, ranging from 0.5 (100 doses/year) to 12 SABA inhalers (2400 doses/year), and complacency in the perception that over-use did not represent a marker for risk of asthma death. Despite current evidence, these findings suggest clinicians of various backgrounds are complacent about excessive SABA use.

References

Feb 20, 1992·The New England Journal of Medicine·W O SpitzerA S Rebuck
Sep 1, 1994·The European Respiratory Journal·S SuissaP Ernst
Jul 10, 2010·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Harris S SilverBenjamin Gutierrez
Oct 29, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Mark L Levy

❮ Previous
Next ❯

Citations

Jul 22, 2021·Journal of Asthma and Allergy·Anna Jetske BaronJanwillem W H Kocks
Jun 17, 2021·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Michael NobleAndrew M Wilson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.